Biostatistics
Biostatistical design and analysis are central elements of any clinical trial. Establishing a sound biostatistical plan results in optimal study design and high-quality data output. Comprehensive statistical input during the early stages of a clinical development program decreases overall costs by accelerates timelines to regulatory approval. In addition, well formulated statistical plans improve the quality of regulatory submissions and increases the likelihood of approval.
Allphase biostatistical personnel keep current in all statistical analysis methodologies and have in-depth understanding of the practices deemed acceptable by regulatory agencies. Our Biostatisticians bring expertise and insight into the development of comprehensive statistical analysis plans (SAPs).
Our team assist our clients in navigating the complex areas of study design, including adaptive trial designs, sample size determinations, stratification methods, interim analysis options, final analysis methods, as well as data presentation, simulation, and interpretations. Our biostatisticians, programmers, and consultants make significant contributions to your drug validation.
For more information click here